Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP

被引:243
作者
Roelofs, Anke J. [2 ]
Jauhiainen, Marjo [1 ]
Monkkonen, Hannu [1 ]
Rogers, Michael J. [2 ]
Monkkonen, Jukka [1 ]
Thompson, Keith [2 ]
机构
[1] Univ Kuopio, Dept Pharmaceut, FIN-70211 Kuopio, Finland
[2] Univ Aberdeen, Inst Med Sci, Bone & Musculoskeletal Res Programme, Aberdeen AB25 2ZD, Scotland
基金
芬兰科学院;
关键词
bisphosphonates; alkylamines; monocytes; gamma delta T cells; isopentenyl diphosphate; BISPHOSPHONATE; AMINOBISPHOSPHONATES; PROLIFERATION; STATINS;
D O I
10.1111/j.1365-2141.2008.07435.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Nitrogen-containing bisphosphonates indirectly activate V gamma 9V delta 2 T cells through inhibition of farnesyl pyrophosphate synthase and intracellular accumulation of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), but the cells responsible for V gamma 9V delta 2 T cell activation through IPP/DMAPP accumulation are unknown. Treatment of human peripheral blood mononuclear cells (PBMCs) with a pharmacologically relevant concentration of zoledronic acid induced accumulation of IPP/DMAPP selectively in monocytes, which correlated with efficient drug uptake by these cells. Furthermore, zoledronic acid-pulsed monocytes triggered activation of gamma delta T cells in a cell contact-dependent manner. These observations identify monocytes as the cell type directly affected by bisphosphonates responsible for V gamma 9V delta 2 T cell activation.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 12 条
[1]
Human Vγ9Vδ2 T cells:: promising new leads for immunotherapy of infections and tumors [J].
Bonneville, Marc ;
Scotet, Emmanuel .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (05) :539-546
[2]
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases [J].
Chen, TL ;
Berenson, J ;
Vescio, R ;
Swift, R ;
Gilchick, A ;
Goodin, S ;
LoRusso, P ;
Ma, PM ;
Ravera, C ;
Deckert, F ;
Schran, H ;
Seaman, J ;
Skerjanec, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11) :1228-1236
[3]
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells [J].
Gober, HJ ;
Kistowska, M ;
Angman, L ;
Jenö, P ;
Mori, L ;
De Libero, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :163-168
[4]
The bisphosphonate acute phase response:: rapid and copious production of proinflammatory cytokines by peripheral blood γδ T cells in response to aminobisphosphonates is inhibited by statins [J].
Hewitt, RE ;
Lissina, A ;
Green, AE ;
Slay, ES ;
Price, DA ;
Sewell, AK .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (01) :101-111
[5]
Kunzmann V, 2000, BLOOD, V96, P384
[6]
Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine [J].
Legay, F ;
Gauron, S ;
Deckert, F ;
Gosset, G ;
Pfaar, U ;
Ravera, C ;
Wiegand, H ;
Schran, H .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (04) :897-911
[7]
Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human γδ T cells by aminobisphosphonate antigen [J].
Miyagawa, F ;
Tanaka, Y ;
Yamashita, S ;
Minato, N .
JOURNAL OF IMMUNOLOGY, 2001, 166 (09) :5508-5514
[8]
A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates [J].
Mönkkönen, H ;
Auriola, S ;
Lehenkari, P ;
Kellinsalmi, M ;
Hassinen, IE ;
Vepsäläinen, J ;
Mönkkönen, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 (04) :437-445
[9]
NATURAL AND SYNTHETIC NONPEPTIDE ANTIGENS RECOGNIZED BY HUMAN GAMMA-DELTA T-CELLS [J].
TANAKA, Y ;
MORITA, CT ;
TANAKA, Y ;
NIEVES, E ;
BRENNER, MB ;
BLOOM, BR .
NATURE, 1995, 375 (6527) :155-158
[10]
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis [J].
Thompson, K ;
Rogers, MJ ;
Coxon, FP ;
Crockett, JC .
MOLECULAR PHARMACOLOGY, 2006, 69 (05) :1624-1632